These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28133180)

  • 1. [Combination Chemotherapy Using Oxaliplatin plus S-1 for Well-Advanced Gastric Cancer].
    Saito H; Suematsu Y; Yamagishi S; Takahashi M; Nakayama M; Fukabori M; Morita A; Wakabayashi K; Itoh Y
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1933-1935. PubMed ID: 28133180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Experience of S-1 and Oxaliplatin(SOX)as the First-Line Chemotherapy for Metastatic/Recurrent Gastric Cancer].
    Toyokawa T; Tamura T; Shibutani M; Ohira G; Yamazoe S; Kimura K; Nagahara H; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2017 May; 44(5):405-408. PubMed ID: 28536336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
    Kim GM; Jeung HC; Rha SY; Kim HS; Jung I; Nam BH; Lee KH; Chung HC
    Eur J Cancer; 2012 Mar; 48(4):518-26. PubMed ID: 22243774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A safety analysis in patients treated with oxaliplatin plus S-1 as adjuvant therapy for gastric cancer].
    Zhou Y; Huang J; Yang L; Chi Y; Qu T; Lü X; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):860-4. PubMed ID: 23291138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y; Hui H; Wang X; Wu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Highly Advanced Gastric Cancer Leading to Immediate Perforation on Day Three of Chemotherapy with S-1 plus Oxaliplatin].
    Neduka H; Munemoto M; Ojima T; Earashi M; Fujii H; Nonomura A
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1939-1941. PubMed ID: 28133182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetexal plus S-1 versus oxaliplatin plus S-1 for first-line treatment of patients with advanced gastric cancer: a retrospective study.
    Wang M; Wu M; Wang W; Wang Q; Wang Y
    Oncol Res Treat; 2014; 37(1-2):24-8. PubMed ID: 24613905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
    Hamakawa T; Kurokawa Y; Takiguchi S; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Mori M; Dok Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2342-4. PubMed ID: 22202376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.
    Hironaka S; Sugimoto N; Yamaguchi K; Moriwaki T; Komatsu Y; Nishina T; Tsuji A; Nakajima TE; Gotoh M; Machida N; Bando H; Esaki T; Emi Y; Sekikawa T; Matsumoto S; Takeuchi M; Boku N; Baba H; Hyodo I
    Lancet Oncol; 2016 Jan; 17(1):99-108. PubMed ID: 26640036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Pathological Complete Response after SOX Chemotherapy in Advanced Gastric Cancer].
    Mori K; Kishi K; Masuzawa T; Tsukada R; Tanemura M; Tei M; Suzuki Y; Otsuka M; Furukawa K; Akamatsu H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2234-2236. PubMed ID: 28133280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of S-1 and oxaliplatin(SOX) plus bevacizumab as first-line therapy in patients with unresectable colorectal cancer].
    Maruo H; Suzuki K; Ishikawa S; Murakami T; Higashi Y; Shoji T; Yamazaki M; Taniguchi M; Nishiyama R
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2583-6. PubMed ID: 25596052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer.
    Zhong DT; Wu RP; Wang XL; Huang XB; Lin MX; Lan YQ; Chen Q
    Pathol Oncol Res; 2015 Sep; 21(4):867-73. PubMed ID: 25648439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.
    Park SR; Kong SY; Rhee J; Park YI; Ryu KW; Lee JH; Kim YW; Choi IJ; Kim CG; Lee JY; Cho SJ; Kim NK
    Ann Oncol; 2011 Apr; 22(4):890-896. PubMed ID: 20860988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
    Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.
    Dai X; Zhang X; Wang C; Jiang J; Wu C
    Oncotarget; 2017 May; 8(18):30495-30501. PubMed ID: 27911869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.
    Lee DJ; Sohn TS; Lim DH; Ahn HK; Park SH; Lee J; Park JO; Park YS; Lim HY; Choi DI; Kim KM; Choi MG; Noh JH; Bae JM; Kim S; Min BH; Kang WK
    Cancer Chemother Pharmacol; 2012 May; 69(5):1333-8. PubMed ID: 22311161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
    Koizumi W; Takiuchi H; Yamada Y; Boku N; Fuse N; Muro K; Komatsu Y; Tsuburaya A
    Ann Oncol; 2010 May; 21(5):1001-5. PubMed ID: 19875759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
    Sato K; Akiyama H; Kogure Y; Suwa Y; Momiyama M; Ishibe A; Endo I
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):329-331. PubMed ID: 28428515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
    Saeki H; Emi Y; Oki E; Tokunaga S; Kakeji Y; Akagi Y; Baba H; Baba E; Maehara Y;
    BMC Cancer; 2018 Jan; 18(1):57. PubMed ID: 29310611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.
    Honma Y; Yamada Y; Terazawa T; Takashima A; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Ohashi M; Morita S; Fukagawa T; Machida N; Katai H
    Surg Today; 2016 Sep; 46(9):1076-82. PubMed ID: 26563224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.